<?xml version="1.0" encoding="UTF-8"?>
<ref id="B144-jcm-09-02084">
 <label>144.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Huet</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Beaussier</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Voisin</surname>
    <given-names>O.</given-names>
   </name>
   <name>
    <surname>Jouveshomme</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Dauriat</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Lazareth</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Sacco</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Naccache</surname>
    <given-names>J.M.</given-names>
   </name>
   <name>
    <surname>BÃ©zie</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Laplanche</surname>
    <given-names>S.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Anakinra for Severe Forms of COVID-19: A Cohort Study</article-title>
  <source>Lancet Rheumatol.</source>
  <year>2020</year>
  <pub-id pub-id-type="doi">10.1016/S2665-9913(20)30164-8</pub-id>
 </element-citation>
</ref>
